The Patent Finder

Signpath Pharma Inc.

Also on record
Records under this name other than the patents Signpath Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.

Showing 1 to 4 of 4 · Back to Signpath Pharma Inc.

PatentTitleStatus Expires Confidence
US 9,138,411Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,004,687Liposomal Curcumin for Treatment of Diseases
Formerly held
Term ended
Term ended Jul 1, 2025 · High confidence
Term endedTerm ended Jul 1, 2025High confidence
US 12,551,436Dosing Regimens for Treatment of Proliferative Disorders
Term ended
Term ended Jul 1, 2025 · High confidence
Term endedTerm ended Jul 1, 2025High confidence
US 9,170,257Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin
Lapsed on the fee record
Ended Oct 27, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 27, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited